French preclinical CRO NovAliX has found a new partner across the pond. Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with ...

Under the collaboration, Topos will leverage Dalriada's expertise and infrastructure in protein mass spectrometry and chemoproteomics to support discovery efforts against intrinsically disordered and ...

The collaboration builds on Biophytis' ongoing partnership with LynxKite and aligns with Singapore’s research, innovation and enterprise (RIE) 2030 plan.

AI-driven drug discovery for next-generation longevity therapies; This partnership will generate revenue through: A co ...

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...

Roche is supercharging drug discovery with a major AI expansion, deploying more than 3,500 NVIDIA Blackwell GPUs worldwide to transform how new medicines are developed. These systems reduce the need ...

In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...

Soley Therapeutics Announces Breakthrough Research Demonstrating How Cellular Stress Responses Reveal Drug Mechanisms, Enabling Entirely New and Accelerated Methods for Drug Discovery Research ...

Dalriada Drug Discovery (Dalriada), a partnered discovery organization supporting small-molecule programmes from hit identification through lead optimization, and Topos Bio (Topos), an AI-native ...